Read + Share
. Azithromycin for community treatment of suspected COVID-19 in people at increased
risk of an adverse clinical course in the UK (PRINCIPLE): a randomised,
controlled, open-label, adaptive platform trial. Lancet 2021 Mar 4. pii: S0140-6736(21)00461.
PMID: 33676597
|
 |
|
